CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Multibagger Alert: This quality pharma stock with high ROE and below industry average PE made fresh all time high on Monday
DSIJ Intelligence
/ Categories: Trending, Mindshare

Multibagger Alert: This quality pharma stock with high ROE and below industry average PE made fresh all time high on Monday

Gujarat Themis Biosyn is a high-quality pharma company displaying a high ROE of 53.66 per cent. This reflects high management efficiency.

The shares of Gujarat Themis Biosyn Ltd jumped higher by 13.74 per cent on Monday, to hit all-time highs. Gujarat Themis Biosyn is a multibagger pharmaceutical company that has soared 171 per cent in one year while in 2021 alone the stock has jumped higher by 121 per cent. In one month alone the stock is up by more than 33 per cent, outperforming the pharma sector and the markets. 

Gujarat Themis Biosyn is a high-quality pharma company displaying a high ROE of 53.66 per cent. This reflects high management efficiency. Available at a PE multiple of ~21 the stock is trading below the industry average PE. 

The financial result has been positive in the latest quarter and technically the stock is in bullish trend both in short term as well as in long term. The shares of multibagger Gujarat Themis Biosyn have consistently outperformed the pharma sector over a long term. In over 5 years the stock has jumped higher by 1021.39 per cent. 

BSE Sensex was down by more than 524 points on Monday even as the BSE Pharma index slipped by 1.70 per cent on closing basis. 

Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with GIIC Ltd. and Chemosyn (P) Ltd. It commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd.

Previous Article These small cap stocks traded at fresh 52 week high on Monday with price volume breakout even as BSE Sensex tumbled
Next Article Small-Cap Funds with best ratings
Print
31911 Rate this article:
3.2

3 comments on article "Multibagger Alert: This quality pharma stock with high ROE and below industry average PE made fresh all time high on Monday"

Avatar image

Anupam Kumar

I looked into AR 2021 and 2020. The is no mention of what are the product and revenue from generated from each pharma product. Though price is increasing but it is better to avoid due to lack of information.


Avatar image

DSIJ Intelligence

Dear Sir,

You are right. Conviction is required to buy any stock.

Happy investing!


Avatar image

Bishnu Pada Sarkar

Without knowing fundamental details mere increase in price of any script may not be a criteria for purchasing the same.

BISHNU PADA SARKAR, MASLANDPUR.

Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR